好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Anti-CD52 treatment induces CD39+ regulatory cells and suppresses EAE disease progression
General Neurology
(-)
002
Authors/Disclosures

PRESENTER
No disclosure on file
No disclosure on file
No disclosure on file
Kiel Telesford No disclosure on file
Javier Ochoa-Reparaz, PhD (Eastern Washington University) No disclosure on file
No disclosure on file
Per Solberg Sorensen, MD, PhD, FAAN (Rigshospitalet Glostrup) Dr. Sorensen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA.
Lloyd H. Kasper, MD (Dartmouth Medical School) No disclosure on file
Sakhina Begum-Haque, PhD (Dartmouth Med School) No disclosure on file